Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFeeling hungry on 5mg Mounjaro is common, and it doesn't mean the medicine isn't working. At this dose, tirzepatide is still finding its footing in your system — appetite suppression tends to build as the dose increases through the titration schedule. That said, persistent hunger at 5mg is worth understanding rather than simply pushing through. It may reflect how the dose interacts with your individual physiology, what you're eating, or where you are in your titration. These are prescription-only medicines; a GPhC-registered prescriber reviews your progress and guides any next steps.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Yes, for a lot of people it is. A question our prescribers hear most weeks is some version of: "I've moved to 5mg and I'm still eating the same amounts, am I doing something wrong?" The honest answer is: probably not. Tirzepatide works by activating two gut-hormone receptors, GIP and GLP-1, and the effect on appetite tends to accumulate as the dose climbs. The 2.5mg starter exists primarily to let your body adjust; 5mg is where therapeutic work begins in earnest, but it's still early in the schedule.
The NHS tirzepatide medicines page notes that nausea and appetite changes are common side effects that vary between individuals, which tells you something useful: the dose-response relationship is personal. Some people notice a sharp drop in hunger at 5mg; others find the shift is gradual and becomes clearer only at 7.5mg or beyond. Neither pattern is wrong. If you're curious about the broader picture of how this medication is structured, the Mounjaro overview covers the full titration context.
One thing that sometimes confuses people: if you're still feeling hungry on the 2.5mg dose, it can help to know that hunger and appetite suppression aren't the same as weight on the scale. You can be losing weight while still feeling hungry between meals, especially in the first weeks at a new dose.
Almost certainly, it's a factor. Tirzepatide slows gastric emptying, which means food stays in your stomach longer, but this effect is more pronounced with certain foods than others. Meals built around protein and fibre tend to extend fullness considerably more than refined carbohydrates, which digest quickly and can leave you hungry again within two hours regardless of what your medication is doing.
At 5mg, when the appetite-suppressing signal is still building, what you eat acts as a significant multiplier. A meal of 30–40g of protein alongside vegetables will keep most people comfortably full for four to five hours. A meal of the same calorie count made up mostly of white bread or sugary snacks won't. This isn't about being strict or following a formal plan; it's just that the medication and the meal choice are working in parallel, and at this dose, diet does more of the heavy lifting than it will at higher doses.
Hydration also matters more than people expect. Thirst and mild hunger feel very similar, and on tirzepatide (where your overall food and fluid intake may be reduced) it's easy to be subtly under-hydrated. Drinking enough water across the day often reduces that background hunger signal noticeably.
Most people who notice a meaningful appetite shift at 5mg report it becoming clearer somewhere between two and four weeks into that dose. The first week after moving up from 2.5mg can actually feel unsettled: some people experience more GI discomfort temporarily, which distracts from appetite signals. By weeks three and four, things tend to stabilise.
If you're several weeks into 5mg and hunger feels entirely unchanged from before you started, that's worth documenting and discussing with your prescriber. It doesn't automatically mean a dose increase is due (prescribers consider the full picture, including any side effects, weight change and how you're tolerating the current pen) but it's the kind of feedback that shapes the clinical conversation. You can read more about experiences at adjacent doses on our page covering hunger at 7.5mg Mounjaro, which many people find instructive for understanding what the next step feels like.
The key point: this isn't a fixed timeline. The SURMOUNT-1 trial, published in the New England Journal of Medicine, ran 72 weeks and showed that weight and appetite outcomes continued to improve through dose increases. Individual variation across that curve is expected and normal.
Tell them sooner than you think. Hunger that hasn't reduced after three or four weeks at 5mg, hunger that seems to be getting worse, or hunger accompanied by dizziness, fatigue or noticeable mood changes all deserve a clinical conversation rather than stoic waiting.
Prescribers look at hunger as a clinical signal, not a complaint. It can indicate that a dose increase is appropriate when the time is right, or it might prompt a conversation about meal composition, sleep (which has a significant effect on appetite hormones), or other factors. Either way, it's information. The 5mg Mounjaro page has more detail on what to expect at this specific dose.
For context on how cost fits into longer treatment, the Mounjaro pricing page is worth a read, particularly if you're thinking ahead to higher doses and want to understand what you're committing to financially before continuing.
If you want to understand exactly how 0.7 ml of the 2.5mg Mounjaro pen is measured and administered, our team at the consultation page can help you understand whether Mounjaro is clinically appropriate for you. Every consultation is reviewed the same day by a real prescriber, a named GPhC-registered clinician reads your answers, not software. That matters when you have specific questions about what to expect.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.